Search Results - "Lynch, DR"

Refine Results
  1. 1

    Interactions between Ifenprodil and the NR2B Subunit of the N-Methyl-D-aspartate Receptor (∗) by Gallagher, Michael J., Huang, Hui, Pritchett, Dolan B., Lynch, David R.

    Published in The Journal of biological chemistry (19-04-1996)
    “…Ifenprodil is an atypical noncompetitive modulator of the N-methyl-D-aspartate (NMDA) receptor (NR) which demonstrates a 140-fold preference for NR2B over NR2A…”
    Get full text
    Journal Article
  2. 2

    Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal by Iizuka, T, Sakai, F, Ide, T, Monzen, T, Yoshii, S, Iigaya, M, Suzuki, K, Lynch, D R, Suzuki, N, Hata, T, Dalmau, J

    Published in Neurology (12-02-2008)
    “…To report the definitive diagnosis of anti-NMDA receptor (NMDAR) encephalitis in four Japanese women previously diagnosed with "juvenile acute nonherpetic…”
    Get full text
    Journal Article
  3. 3

    Pharmacological therapeutics in Friedreich ataxia: the present state by Strawser, Cassandra, Schadt, Kimberly, Hauser, Lauren, McCormick, Ashley, Wells, McKenzie, Larkindale, Jane, Lin, Hong, Lynch, David R

    Published in Expert review of neurotherapeutics (02-09-2017)
    “…Friedreich ataxia (FRDA) is a progressive, inherited, neurodegenerative disease for which there is currently no cure or approved treatment. FRDA is caused by…”
    Get more information
    Journal Article
  4. 4
  5. 5

    N-methyl-D-aspartate Receptor Subtypes: Multiple Roles in Excitotoxicity and Neurological Disease by Waxman, Elisa A., Lynch, David R.

    Published in The Neuroscientist (01-02-2005)
    “…N-methyl-D-aspartate (NMDA) receptors are the major mediator of excitotoxicity. Although physiological activation of the NMDA receptor is necessary for cell…”
    Get full text
    Book Review Journal Article
  6. 6

    Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study by Meier, Thomas, Perlman, Susan L., Rummey, Christian, Coppard, Nicholas J., Lynch, David R.

    Published in Journal of neurology (01-02-2012)
    “…The aim of this study was to investigate the efficacy of idebenone on neurological function as assessed by ICARS and FARS neurological rating scales in…”
    Get full text
    Journal Article
  7. 7

    Open-label pilot study of interferon gamma-1b in Friedreich ataxia by Seyer, L., Greeley, N., Foerster, D., Strawser, C., Gelbard, S., Dong, Y., Schadt, K., Cotticelli, M. G., Brocht, A., Farmer, J., Wilson, R. B., Lynch, D. R.

    Published in Acta neurologica Scandinavica (01-07-2015)
    “…Objectives/Aims This is an open‐label trial of the safety of interferon gamma‐1b (IFN‐γ) and its effect on frataxin levels and neurologic measures in 12…”
    Get full text
    Journal Article
  8. 8

    The E46K mutation in alpha-synuclein increases amyloid fibril formation by Greenbaum, Eric A, Graves, Charles L, Mishizen-Eberz, Amanda J, Lupoli, Michael A, Lynch, David R, Englander, S Walter, Axelsen, Paul H, Giasson, Benoit I

    Published in The Journal of biological chemistry (04-03-2005)
    “…The identification of a novel mutation (E46K) in one of the KTKEGV-type repeats in the amino-terminal region of alpha-synuclein suggests that this region and,…”
    Get full text
    Journal Article
  9. 9

    Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation by Hodara, Roberto, Norris, Erin H, Giasson, Benoit I, Mishizen-Eberz, Amanda J, Lynch, David R, Lee, Virginia M-Y, Ischiropoulos, Harry

    Published in The Journal of biological chemistry (12-11-2004)
    “…Previous studies have shown the presence of nitrated alpha-synuclein (alpha-syn) in human Lewy bodies and other alpha-syn inclusions. Herein, the effects of…”
    Get full text
    Journal Article
  10. 10

    Idebenone in Friedreich ataxia cardiomyopathy—results from a 6-month phase III study (IONIA) by Lagedrost, Sarah J., BA, Sutton, Martin St. John, MBBS, Cohen, Meryl S., MD, Satou, Gary M., MD, Kaufman, Beth D., MD, Perlman, Susan L., MD, Rummey, Christian, PhD, Meier, Thomas, PhD, Lynch, David R., MD, PhD

    Published in The American heart journal (01-03-2011)
    “…Background Friedreich ataxia (FRDA) is commonly associated with hypertrophic cardiomyopathy, but little is known about its frequency, severity, or treatment…”
    Get full text
    Journal Article
  11. 11

    Excitotoxicity: perspectives based on N-methyl-D-aspartate receptor subtypes by Lynch, David R, Guttmann, Rodney P

    “…Since excitotoxicity has been implicated in a variety of neuropathological conditions, understanding the pathways involved in this type of cell death is of…”
    Get more information
    Journal Article
  12. 12

    Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: New diagnostic criteria by BRUNO, M. K, HALLETT, M, SOONG, B.-W, ASHIZAWA, T, JANKOVIC, J, RENNER, D, FU, Y.-H, PTACEK, L. J, GWINN-HARDY, K, SORENSEN, B, CONSIDINE, E, TUCKER, S, LYNCH, D. R, MATHEWS, K. D, SWOBODA, K. J, HARRIS, J

    Published in Neurology (28-12-2004)
    “…Paroxysmal kinesigenic dyskinesia (PKD) is a rare disorder characterized by short episodes of involuntary movement attacks triggered by sudden voluntary…”
    Get full text
    Journal Article
  13. 13

    Therapeutic approaches for the treatment of Friedreich's ataxia by Strawser, Cassandra J, Schadt, Kimberly A, Lynch, David R

    Published in Expert review of neurotherapeutics (01-08-2014)
    “…Friedreich ataxia (FRDA) is an inherited, progressive, neurodegenerative disease for which there is presently no cure or effective therapeutic intervention…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Measuring Friedreich ataxia : Complementary features of examination and performance measures by LYNCH, D. R, FARMER, J. M, TSOU, A. Y, PERLMAN, S, SUBRAMONY, S. H, GOMEZ, C. M, ASHIZAWA, T, WILMOT, G. R, WILSON, R. B, BALCER, L. J

    Published in Neurology (13-06-2006)
    “…To examine the potential validity of performance measures and examination-based scales in Friedreich ataxia (FA) by examining their correlation with disease…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Tomato Ve Disease Resistance Genes Encode Cell Surface-like Receptors by Kawchuk, Lawrence M., Hachey, John, Lynch, Dermot R., Kulcsar, Frank, van Rooijen, Gijs, Waterer, Doug R., Robertson, Albert, Kokko, Eric, Byers, Robert, Howard, Ronald J., Fischer, Rainer, Prüfer, Dirk

    “…In tomato, Ve is implicated in race-specific resistance to infection by Verticillium species causing crop disease. Characterization of the Ve locus involved…”
    Get full text
    Journal Article
  18. 18

    Mechanisms regulating large-scale seasonal fluctuations in Alexandrium fundyense populations in the Gulf of Maine: Results from a physical–biological model by McGillicuddy, D.J., Anderson, D.M., Lynch, D.R., Townsend, D.W.

    “…Observations of Alexandrium fundyense in the Gulf of Maine indicate several salient characteristics of the vegetative cell distributions: patterns of abundance…”
    Get full text
    Journal Article
  19. 19

    Seasonal mean circulation in the Yellow Sea — a model-generated climatology by E. Naimie, Christopher, Ann Blain, Cheryl, R. Lynch, Daniel

    Published in Continental shelf research (01-04-2001)
    “…The three-dimensional climatological circulation is computed for the Yellow and Bohai Seas in a series of six bimonthly realizations. The model (QUODDY, Lynch…”
    Get full text
    Journal Article
  20. 20

    N-Methyl-D-aspartate Receptor Subtype Mediated Bidirectional Control of p38 Mitogen-activated Protein Kinase by Waxman, Elisa A., Lynch, David R.

    Published in The Journal of biological chemistry (12-08-2005)
    “…N-methyl-d-aspartate receptor (NMDAR) stimulation activates many downstream mechanisms involved in both cell survival and cell death. The manner in which the…”
    Get full text
    Journal Article